GAF Healthcare

Best Hematologists for CAR-T Cell Therapy in Delhi NCR, India

This page lists 5 car-t cell therapy doctors in Delhi NCR, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

Quick answer

This page lists 5 car-t cell therapy doctors in Delhi NCR, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

About CAR-T Cell Therapy doctors in Delhi NCR, India

This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.

CAR-T Cell Therapy doctors

Image not available Featured

Dr. Gaurav Dixit

MBBS, MD (General Medicine), DM (Clinical Haematology), Professional Certificate in Multiple Myeloma
Head — Haematology Oncology & Bone Marrow Transplant (Unit II) · Specialty: Hematologist & BMT Specialist
Artemis Hospital Gurgaon, India17+ Years experience
Why consider this doctor?
  • 17+ years of experience in Hematologist & BMT Specialist
  • Head — Haematology Oncology & Bone Marrow Transplant (Unit II), Artemis Hospital, Gurugram (Present)
  • Senior Consultant — Haematology & BMT, Action Cancer Hospital, Delhi (~4 years)
Expertise & Procedures
  • Autologous Stem Cell Transplant
  • Matched Sibling Allogeneic Stem Cell Transplant
  • Haploidentical Stem Cell Transplant
  • Matched Unrelated Donor Transplant
  • Bone Marrow Aspiration & Biopsy
View all procedures →
Hematologist & BMT Specialist Experience: 17+ YearsHospital Affiliation: Artemis HospitalHospital accreditation: JCI, NABH
View Profile Book a Consultation
Dr. Rayaz Ahmed

Dr. Rayaz Ahmed

MBBS, MD (Pathology), DM (Clinical Hematology)
Director — Hematology & Bone Marrow Transplantation · Specialty: Hematologist & BMT Specialist
Max Super Speciality Hospital, Saket New Delhi, India20+ Years experience
Why consider this doctor?
  • 20+ years of experience in Hematologist & BMT Specialist
  • Director — Hematology & Bone Marrow Transplantation, Max Super Speciality Hospital, Saket, New Delhi (Present)
  • Senior Consultant — Department of Hematology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi
Expertise & Procedures
  • Autologous bone marrow / peripheral blood stem cell transplant
  • Allogeneic matched sibling donor stem cell transplant
  • Haplo-identical stem cell transplant
  • Matched unrelated donor stem cell transplant
  • Bone marrow aspiration and biopsy
View all procedures →
Hematologist & BMT Specialist Experience: 20+ YearsHospital Affiliation: Max Super Speciality Hospital, SaketHospital accreditation: NABH, JCI
View Profile Book a Consultation
Image not available

Dr. Meet Kumar

MBBS, MD, DM (Clinical Hematology), Fellowship in Bone Marrow Transplant
Director & HOD — Hemato-Oncology & Bone Marrow Transplant · Specialty: Hematologist & Bone Marrow Transplant Specialist
Marengo Asia Hospitals Faridabad, India18+ Years experience
Why consider this doctor?
  • 18+ years of experience in Hematologist & Bone Marrow Transplant Specialist
  • Director & Head of Department, Hemato-Oncology & Bone Marrow Transplant, Marengo Asia Hospitals, Faridabad — Present
  • Senior Consultant, BLK Hospital, Delhi
Expertise & Procedures
  • Bone Marrow Transplant (BMT)
  • Autologous Stem Cell Transplant (ASCT)
  • Allogeneic Bone Marrow Transplant
  • Haploidentical Bone Marrow Transplant
  • Matched Unrelated Donor (MUD) Transplant
View all procedures →
Hematologist & Bone Marrow Transplant Specialist Experience: 18+ YearsHospital Affiliation: Marengo Asia HospitalsHospital accreditation: NABH, NABL
View Profile Book a Consultation
Image not available

Dr. Satya Prakash Yadav

MBBS, DCH, DNB, Fellow in Paediatric Haematology-Oncology
Senior Director — Pediatric Hematology · Specialty: Pediatric Hematologist & Bone Marrow Transplant Specialist
Medanta - The Medicity Gurgaon, India32+ Years experience
Why consider this doctor?
  • 32+ years of experience in Pediatric Hematologist & Bone Marrow Transplant Specialist
  • Senior Director, Pediatric Hematology & Bone Marrow Transplant, Medanta – The Medicity, Gurgaon
  • Established pediatric bone marrow transplant program, Fortis Gurugram
Expertise & Procedures
  • Matched Sibling Donor Bone Marrow Transplant
  • Matched Unrelated Donor Bone Marrow Transplant
  • Haploidentical Bone Marrow Transplant
  • Umbilical Cord Blood Stem Cell Transplant
  • CAR-T Cell Therapy Administration
View all procedures →
Pediatric Hematologist & Bone Marrow Transplant Specialist Experience: 32+ YearsHospital Affiliation: Medanta - The MedicityHospital accreditation: JCI, NABH
View Profile Book a Consultation
Image not available

Dr. Tejasvini Vaid

MBBS, MD, DM
Consultant — Hematology & Bone Marrow Transplant · Specialty: Hematologist & BMT Specialist
Medanta – The Medicity Delhi NCR, India12+ Years experience
Why consider this doctor?
  • 12+ years of experience in Hematologist & BMT Specialist
  • Consultant — Hematology & Bone Marrow Transplant, Medanta – The Medicity, Delhi NCR, India (Present)
  • Global Clinical Scholar, Harvard Medical School, Boston, USA (2023)
Expertise & Procedures
  • Bone Marrow Transplantation (Allogeneic and Autologous)
  • CAR-T Cell Therapy
  • Stem Cell Transplantation
  • Bone Marrow Biopsy and Aspiration
  • Peripheral Blood Stem Cell Collection
View all procedures →
Hematologist & BMT Specialist Experience: 12+ YearsHospital Affiliation: Medanta – The MedicityHospital accreditation: JCI, NABH
View Profile Book a Consultation

Hospitals where these doctors practise

Artemis Hospital🇮🇳 Gurgaon, India
Starting from$35,000

Artemis Hospital

Est. 2007
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
CAR-T Cell TherapyHematologyCardiac SurgeryCardiology
1+
Doctors for CAR-T Cell Therapy
4.9
64 reviews
750+
Beds
19+
Years Since Founded
Dr. Gaurav Dixit
View Hospital Profile Enquire / Get Free Opinion
Marengo Asia Hospitals🇮🇳 Faridabad, India
Starting from$35,000

Marengo Asia Hospitals

Est. 2007
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
CAR-T Cell TherapyHematologyCardiac SurgeryCardiology
1+
Doctors for CAR-T Cell Therapy
4.4
54 reviews
450+
Beds
19+
Years Since Founded
Dr. Meet Kumar
View Hospital Profile Enquire / Get Free Opinion
Medanta - The Medicity🇮🇳 Gurgaon, India
Starting from$35,000

Medanta - The Medicity

Est. 2009
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
CAR-T Cell TherapyHematologyCardiac SurgeryCardiology
2+
Doctors for CAR-T Cell Therapy
4.9
2150 reviews
1600+
Beds
17+
Years Since Founded
Dr. Satya Prakash YadavDr. Tejasvini Vaid
View Hospital Profile Enquire / Get Free Opinion

Why consider treatment in India?

Many international patients consider India for acute leukemia treatment for several reasons, including:

More affordable estimates

Competitive indicative costs compared with many other countries, for similar clinical standards.

Internationally accredited hospitals

Hospitals experienced in treating international patients.

Experienced specialists

Doctors who regularly manage similar cases.

Care coordination support

A team to help with planning, medical translation and follow-up.

About the Procedure

What is CAR-T Cell Therapy?

CAR T-Cell Therapy is an advanced form of immunotherapy in which a patient's own T-cells are genetically re-engineered in a laboratory to recognize and destroy cancer cells, then infused back into the body. It is primarily used for certain relapsed or refractory blood cancers such as B-cell lymphoma, acute lymphoblastic leukemia (ALL), and multiple myeloma when standard chemotherapy or transplant options have failed. India offers this therapy at a fraction of Western costs, including access to India's own indigenously developed CAR-T product.

Who may be considered?

CAR-T Cell Therapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.

How does it work?

Uses globally licensed CAR-T products manufactured overseas and imported to India, where T-cells are collected, sent for engineering, and re-infused under strict hospital protocols.

2 approaches available for this procedure:

Commercial/Approved CAR T-Cell Therapy (e.g., Tisagenlecleucel, Axicabtagene)

Internationally Approved

Uses globally licensed CAR-T products manufactured overseas and imported to India, where T-cells are collected, sent for engineering, and re-infused under strict hospital protocols.

Comprehensive Investigations

Estimated cost: $1,500 - $3,500

CBC, comprehensive metabolic panel, LDH, PET-CT scan, bone marrow biopsy, cardiac ECG/echocardiogram, pulmonary function test, HIV/Hepatitis B & C screening, HLA typing

Treatment / Procedure Estimate

Estimated cost in India: $120,000 - $220,000

Stay in India

Pre-procedure stay (outside hospital): ~5-7 days
Hospitalisation: ~14-21 days
Recovery period (outside hospital): ~30-60 days recommended
Total stay: approx 45-75 days

Usually Included in Hospital Package

  • Leukapheresis (T-cell collection)
  • CAR-T cell manufacturing and shipping coordination
  • Lymphodepleting chemotherapy
  • CAR-T cell infusion under monitored ICU-ready setup
  • Management of cytokine release syndrome (CRS) if it occurs
  • Inpatient nursing and physician care

Usually Not Included

  • International product import/logistics fees (may vary)
  • Extended ICU stay beyond standard protocol
  • Post-discharge medications and long-term follow-up visits
  • Airfare and accommodation for patient/attendant
  • Visa and travel insurance

Recovery and follow-up

Patients typically remain near the treatment center for 3-4 weeks after infusion for close monitoring of side effects such as cytokine release syndrome, followed by regular blood tests and imaging over the following months to assess response. Long-term follow-up every few months is recommended to monitor for relapse and delayed immune effects.

Risks

Key risks include cytokine release syndrome (CRS), neurotoxicity, prolonged low blood counts, and increased susceptibility to infections due to temporary immune suppression. Rare but serious complications can require intensive care support, making treatment at a well-equipped center essential.

Alternatives

Alternatives depending on disease type and stage may include allogeneic or autologous stem cell transplant, targeted monoclonal antibody therapy, bispecific antibody therapy, or continued conventional chemotherapy regimens. The suitability of each option should be discussed with a hematologist-oncologist based on prior response and disease biology.

What we need to prepare a formal estimate

Share whatever you have — the care team will confirm the final checklist after reviewing your case.

Reports required

  • Complete blood count (CBC) and metabolic panel
  • PET-CT scan showing disease status
  • Bone marrow biopsy report (if applicable)
  • Prior treatment history including chemotherapy/transplant records
  • Pathology report confirming cancer subtype (immunophenotyping)
  • Cardiac evaluation (ECG/echocardiogram)
  • Pulmonary function test report
  • HIV, Hepatitis B & C screening results

Patient information needed

  • Confirmed cancer diagnosis and subtype with staging details
  • History of previous treatments including chemotherapy, radiation, or stem cell transplant
  • Current performance status (ability to carry out daily activities)
  • List of current medications and allergies
  • Presence of any active infections or organ dysfunction
  • Availability of a caregiver for extended hospital stay
  • Insurance or payment plan details
  • Passport and visa readiness for medical travel

Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.

Want a formal estimate?

Share your reports and patient information so our care coordination team can review your case.

How this directory is built

Doctors are matched using the specialty, location, condition (CAR-T Cell Therapy) and procedure (CAR-T Cell Therapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.

Need help with the next step?

Share your needs with our care coordination team for information about doctors and hospitals.

Common questions

FAQs about CAR-T Cell Therapy in Delhi NCR, India

What is Acute Leukemia?
Acute leukemia is a fast-moving cancer that originates in the bone marrow, causing a rapid buildup of abnormal, immature blood cells that interfere with normal blood function. It is classified as either lymphoblastic (ALL) or myeloid (AML) depending on the type of blood cell affected.
What are the symptoms and health risks of Acute Leukemia?
Common symptoms include persistent fatigue, unexplained bruising or bleeding, frequent infections, fever, bone or joint pain, swollen lymph nodes, and unusual paleness. Because acute leukemia progresses quickly, symptoms can appear and worsen over days to weeks rather than months. These symptoms can overlap with many other conditions, so their presence alone is not sufficient to establish a diagnosis — a qualified clinician must evaluate you.
How is Acute Leukemia diagnosed?
Diagnosis typically begins with a full blood count (CBC), which may reveal abnormal blast cell levels, followed by a bone marrow biopsy and aspirate to confirm the presence and percentage of blast cells — with 20% or more blasts generally meeting the threshold for acute leukemia. Further investigations, including immunophenotyping, cytogenetic analysis (karyotyping), and molecular testing for mutations such as FLT3, NPM1, or BCR-ABL, are used to classify the specific subtype and identify risk category (favorable, intermediate, or adverse), all of which directly shape the treatment plan. Lumbar puncture may also be performed to determine whether the central nervous system is involved.
How is Acute Leukemia treated?
Treatment approach depends on the leukemia subtype, cytogenetic and molecular risk profile, the patient's age, overall health, and response to initial therapy. The primary treatment pathway for most patients is intensive chemotherapy — typically delivered in phases of induction, consolidation, and maintenance — with the goal of achieving and sustaining complete remission. For eligible patients, particularly those with high-risk disease or relapse, an allogeneic bone marrow (stem cell) transplant may be recommended, and CAR-T cell therapy is an established option for certain relapsed or refractory cases, notably ALL.
Can Acute Leukemia be treated without a procedure?
Acute leukemia has no meaningful watchful-waiting or lifestyle-only management pathway — the disease progresses rapidly and requires prompt medical intervention. That said, not all treatment is procedural: systemic chemotherapy, targeted therapies (such as tyrosine kinase inhibitors for Philadelphia chromosome-positive disease), and immunotherapy are non-surgical treatment backbones that a clinician may use alone or in combination before determining whether a transplant or cellular therapy is appropriate.
When is CAR-T Cell Therapy considered for Acute Leukemia?
CAR-T Cell Therapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Acute Leukemia?
Acute leukemia is primarily evaluated and managed by a hematologist-oncologist specializing in blood cancers. When bone marrow transplantation is under consideration, a transplant hematologist or bone marrow transplant specialist becomes central to the care team, often supported by specialists in infectious disease, transfusion medicine, and clinical pharmacology.
How do I choose a doctor for Acute Leukemia?
When selecting a provider for acute leukemia, look for a hematologist-oncologist with documented experience in your specific leukemia subtype, based at a center with an accredited bone marrow transplant program and access to CAR-T cell therapy, so that the full range of treatment options — including clinical trials — remains available to you if needed. Ask about the center's multidisciplinary tumor board, its remission and transplant outcome data, and how ongoing monitoring and relapse management are coordinated.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.
WhatsApp Us